Fourth, that chromosomal arm-level alterations, hormone receptor signalling and specific genes, including C19orf57 are associated with this high cell cycle activity in gynaecological tumours and finally, that C19orf57 also shows a moderate association with BC-CCS at a pan-cancer level. Here, BRME1 is linked to breast cancer.